Double Medical Technology Inc
Double Medical Technology Inc. engages in the research, development, production, sale, and high-value medical consumables in China. The company provides products for orthopedics, minimally invasive surgery, neurosurgery, wound surgery, and dentistry, etc. It also exports its products to various countries and regions. The company was formerly known as Xiamen Da Bo Ying Jing Medical Equipment Compa… Read more
Double Medical Technology Inc (002901) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.060x
Based on the latest financial reports, Double Medical Technology Inc (002901) has a cash flow conversion efficiency ratio of 0.060x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥207.34 Million) by net assets (CN¥3.44 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Double Medical Technology Inc - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how Double Medical Technology Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Double Medical Technology Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Double Medical Technology Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
BSR Real Estate Investment Trust
PINK:BSRTF
|
0.016x |
|
Grupo Mateus S.A
SA:GMAT3
|
0.022x |
|
Farglory Land Development Co Ltd
TW:5522
|
0.056x |
|
Mesa Laboratories Inc
NASDAQ:MLAB
|
0.100x |
|
Maharashtra Seamless Limited
NSE:MAHSEAMLES
|
0.066x |
|
Amaroq Ltd.
PINK:AMRQF
|
-0.038x |
|
Formosa Taffeta Co Ltd
TW:1434
|
0.022x |
|
Canopy Growth Corp
NASDAQ:CGC
|
-0.023x |
Annual Cash Flow Conversion Efficiency for Double Medical Technology Inc (2013–2024)
The table below shows the annual cash flow conversion efficiency of Double Medical Technology Inc from 2013 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥3.18 Billion | CN¥442.30 Million | 0.139x | +494.63% |
| 2023-12-31 | CN¥3.16 Billion | CN¥73.89 Million | 0.023x | -43.45% |
| 2022-12-31 | CN¥3.11 Billion | CN¥128.44 Million | 0.041x | -84.11% |
| 2021-12-31 | CN¥2.59 Billion | CN¥673.26 Million | 0.260x | -0.13% |
| 2020-12-31 | CN¥2.13 Billion | CN¥555.77 Million | 0.260x | +5.26% |
| 2019-12-31 | CN¥1.75 Billion | CN¥433.88 Million | 0.247x | +7.72% |
| 2018-12-31 | CN¥1.46 Billion | CN¥334.88 Million | 0.230x | -7.84% |
| 2017-12-31 | CN¥1.24 Billion | CN¥308.70 Million | 0.249x | -30.19% |
| 2016-12-31 | CN¥580.13 Million | CN¥207.13 Million | 0.357x | +27.78% |
| 2015-12-31 | CN¥441.78 Million | CN¥123.44 Million | 0.279x | -49.27% |
| 2014-12-31 | CN¥274.36 Million | CN¥151.12 Million | 0.551x | +16.16% |
| 2013-12-31 | CN¥224.61 Million | CN¥106.51 Million | 0.474x | -- |